Cargando…

Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup

SIMPLE SUMMARY: While most neuroendocrine neoplasms are indolent and slow-growing tumors, subsets of cases will spread beyond the tissue of origin. Given the rather slow progress, some lesions are incidentally discovered as metastatic deposits rather than primary masses. In these cases, a biopsy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Juhlin, Carl Christofer, Zedenius, Jan, Höög, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100271/
https://www.ncbi.nlm.nih.gov/pubmed/35565339
http://dx.doi.org/10.3390/cancers14092210
_version_ 1784706812577054720
author Juhlin, Carl Christofer
Zedenius, Jan
Höög, Anders
author_facet Juhlin, Carl Christofer
Zedenius, Jan
Höög, Anders
author_sort Juhlin, Carl Christofer
collection PubMed
description SIMPLE SUMMARY: While most neuroendocrine neoplasms are indolent and slow-growing tumors, subsets of cases will spread beyond the tissue of origin. Given the rather slow progress, some lesions are incidentally discovered as metastatic deposits rather than primary masses. In these cases, a biopsy is often taken to allow the pathologist to identify the tumor type and possibly the primary tumor site via microscopic examination. In this review, the authors present a simplified guide on how to approach metastatic neuroendocrine tumors from a pathologist’s perspective. ABSTRACT: Neuroendocrine neoplasms (NENs) are diverse tumors arising in various anatomical locations and may therefore cause a variety of symptoms leading to their discovery. However, there are instances in which a NEN first presents clinically as a metastatic deposit, while the associated primary tumor is not easily identified using conventional imaging techniques because of small primary tumor sizes. In this setting (which is referred to as a “NEN of unknown primary”; NEN-UP), a tissue biopsy is often procured to allow the surgical pathologist to diagnose the metastatic lesion. If indeed a metastatic NEN-UP is found, several clues can be obtained from morphological assessment and immunohistochemical staining patterns that individually or in concert may help identify the primary tumor site. Herein, histological and auxiliary analyses of value in this context are discussed in order to aid the pathologist when encountering these lesions in clinical practice.
format Online
Article
Text
id pubmed-9100271
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91002712022-05-14 Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup Juhlin, Carl Christofer Zedenius, Jan Höög, Anders Cancers (Basel) Review SIMPLE SUMMARY: While most neuroendocrine neoplasms are indolent and slow-growing tumors, subsets of cases will spread beyond the tissue of origin. Given the rather slow progress, some lesions are incidentally discovered as metastatic deposits rather than primary masses. In these cases, a biopsy is often taken to allow the pathologist to identify the tumor type and possibly the primary tumor site via microscopic examination. In this review, the authors present a simplified guide on how to approach metastatic neuroendocrine tumors from a pathologist’s perspective. ABSTRACT: Neuroendocrine neoplasms (NENs) are diverse tumors arising in various anatomical locations and may therefore cause a variety of symptoms leading to their discovery. However, there are instances in which a NEN first presents clinically as a metastatic deposit, while the associated primary tumor is not easily identified using conventional imaging techniques because of small primary tumor sizes. In this setting (which is referred to as a “NEN of unknown primary”; NEN-UP), a tissue biopsy is often procured to allow the surgical pathologist to diagnose the metastatic lesion. If indeed a metastatic NEN-UP is found, several clues can be obtained from morphological assessment and immunohistochemical staining patterns that individually or in concert may help identify the primary tumor site. Herein, histological and auxiliary analyses of value in this context are discussed in order to aid the pathologist when encountering these lesions in clinical practice. MDPI 2022-04-28 /pmc/articles/PMC9100271/ /pubmed/35565339 http://dx.doi.org/10.3390/cancers14092210 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Juhlin, Carl Christofer
Zedenius, Jan
Höög, Anders
Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title_full Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title_fullStr Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title_full_unstemmed Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title_short Metastatic Neuroendocrine Neoplasms of Unknown Primary: Clues from Pathology Workup
title_sort metastatic neuroendocrine neoplasms of unknown primary: clues from pathology workup
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100271/
https://www.ncbi.nlm.nih.gov/pubmed/35565339
http://dx.doi.org/10.3390/cancers14092210
work_keys_str_mv AT juhlincarlchristofer metastaticneuroendocrineneoplasmsofunknownprimarycluesfrompathologyworkup
AT zedeniusjan metastaticneuroendocrineneoplasmsofunknownprimarycluesfrompathologyworkup
AT hooganders metastaticneuroendocrineneoplasmsofunknownprimarycluesfrompathologyworkup